Correlation Between ProMIS Neurosciences and Hemogenyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ProMIS Neurosciences and Hemogenyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProMIS Neurosciences and Hemogenyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProMIS Neurosciences and Hemogenyx Pharmaceuticals Plc, you can compare the effects of market volatilities on ProMIS Neurosciences and Hemogenyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProMIS Neurosciences with a short position of Hemogenyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProMIS Neurosciences and Hemogenyx Pharmaceuticals.
Diversification Opportunities for ProMIS Neurosciences and Hemogenyx Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ProMIS and Hemogenyx is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and Hemogenyx Pharmaceuticals Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hemogenyx Pharmaceuticals and ProMIS Neurosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProMIS Neurosciences are associated (or correlated) with Hemogenyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hemogenyx Pharmaceuticals has no effect on the direction of ProMIS Neurosciences i.e., ProMIS Neurosciences and Hemogenyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between ProMIS Neurosciences and Hemogenyx Pharmaceuticals
Considering the 90-day investment horizon ProMIS Neurosciences is expected to generate 0.62 times more return on investment than Hemogenyx Pharmaceuticals. However, ProMIS Neurosciences is 1.61 times less risky than Hemogenyx Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Hemogenyx Pharmaceuticals Plc is currently generating about -0.13 per unit of risk. If you would invest 159.00 in ProMIS Neurosciences on August 25, 2024 and sell it today you would lose (56.00) from holding ProMIS Neurosciences or give up 35.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.21% |
| Values | Daily Returns |
ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc
Performance |
| Timeline |
| ProMIS Neurosciences |
| Hemogenyx Pharmaceuticals |
ProMIS Neurosciences and Hemogenyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProMIS Neurosciences and Hemogenyx Pharmaceuticals
The main advantage of trading using opposite ProMIS Neurosciences and Hemogenyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProMIS Neurosciences position performs unexpectedly, Hemogenyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemogenyx Pharmaceuticals will offset losses from the drop in Hemogenyx Pharmaceuticals' long position.| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |